Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer
Yunfeng Bai(Purdue University West Lafayette), Xiaoqi Liu(Indiana University Health), Lijun Cheng(The Ohio State University), Lang Li(Sun Yat-sen University), Feng Feng(Shanxi Datong University), Zhuangzhuang Zhang(University of Kentucky), Xiaoliang Chen(Xihua University), Nihal Ahmad(University of Wisconsin–Madison), Ruixin Wang(University of Kentucky), Yifan Kong(The University of Texas MD Anderson Cancer Center)
Cited by 83
Related Papers
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
|PLoS ONE|2011|437
Genetic Control of Individual Differences in Gene-Specific Methylation in Human Brain
|The American Journal of Human Genetics|2010|394
Transcriptome and epigenome landscape of human cortical development modeled in organoids
|Science|2018|314
Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer
|BMC Genomics|2016|228
Two gene co-expression modules differentiate psychotics and controls
|Molecular Psychiatry|2012|166